HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Bastard Selected Research

Messenger RNA (mRNA)

12/2023Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Bastard Research Topics

Disease

56COVID-19
04/2024 - 10/2020
37Pneumonia (Pneumonitis)
04/2024 - 10/2020
11Infections
05/2024 - 01/2019
6Critical Illness (Critically Ill)
12/2023 - 01/2021
5COVID-19 related pediatric multisystem inflammatory disease
10/2023 - 01/2022
5Inflammation (Inflammations)
12/2022 - 12/2020
3Communicable Diseases (Infectious Diseases)
05/2024 - 01/2022
3Candidiasis (Moniliasis)
05/2024 - 01/2022
3Virus Diseases (Viral Diseases)
05/2024 - 11/2023
3Autoimmune Diseases (Autoimmune Disease)
03/2024 - 03/2022
3Human Influenza (Influenza)
11/2022 - 01/2022
2Herpes Zoster
01/2024 - 12/2022
2Encephalitis (Encephalitis, Rasmussen)
10/2023 - 01/2023
2Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
10/2022 - 03/2022
2Cytokine Release Syndrome
01/2022 - 01/2021
1Meningococcal Meningitis
05/2024
1Neutropenia
05/2024
1Bacterial Infections (Bacterial Infection)
05/2024
1Osteosarcoma (Osteogenic Sarcoma)
04/2024
1Epstein-Barr Virus Infections
03/2024
1Infectious Mononucleosis (Glandular Fever)
03/2024
1Emerging Communicable Diseases (Emerging Infectious Diseases)
03/2024
1Diabetes Insipidus
12/2023
1Hypoparathyroidism
12/2023
1Keratitis
12/2023
1Alopecia (Baldness)
12/2023
1Exocrine Pancreatic Insufficiency
12/2023
1Autoimmune Hepatitis
12/2023
1Autoimmune Polyendocrinopathies (Schmidt Syndrome)
11/2023
1Idiopathic Pulmonary Fibrosis
03/2023
1Down Syndrome (Down's Syndrome)
01/2023
1Chronic Mucocutaneous Candidiasis
01/2023
1West Nile Fever
01/2023
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2022
1Breakthrough Infections
06/2022
1Neoplasms (Cancer)
01/2022
1Pulmonary Alveolar Proteinosis
01/2022
1Yellow Fever
01/2021
1Coronavirus Infections
01/2021
1Disease Progression
01/2021
1Asymptomatic Infections
01/2021
1Eosinophilia
01/2021

Drug/Important Bio-Agent (IBA)

48AutoantibodiesIBA
05/2024 - 10/2020
32Interferon Type IIBA
05/2024 - 10/2020
14AntibodiesIBA
12/2023 - 01/2021
8InterferonsIBA
04/2024 - 10/2020
7CytokinesIBA
05/2024 - 01/2021
5Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2022
4Neutralizing AntibodiesIBA
12/2023 - 01/2022
4Antiviral Agents (Antivirals)IBA
01/2023 - 10/2021
3Interleukin-6 (Interleukin 6)IBA
05/2024 - 01/2022
3VaccinesIBA
06/2022 - 01/2021
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2024 - 01/2022
2SteroidsIBA
12/2023 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2023 - 03/2021
2COVID-19 VaccinesIBA
12/2022 - 06/2022
2AutoantigensIBA
10/2022 - 03/2022
2AntigensIBA
10/2022 - 03/2022
22- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
10/2022 - 03/2022
2Monoclonal AntibodiesIBA
01/2022 - 01/2021
2EpitopesIBA
09/2021 - 03/2021
1ProperdinIBA
05/2024
1Complement System Proteins (Complement)IBA
05/2024
1A-factor (Streptomyces)IBA
05/2024
1Complement C3-C5 Convertases (C3 Convertase)IBA
05/2024
1Interleukin-17 (Interleukin 17)IBA
05/2024
1Interferon-gamma (Interferon, gamma)IBA
05/2024
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024
1Interleukin-27 (Interleukin 27)IBA
03/2024
1HLA-DRB1 Chains (HLA DRB1)IBA
03/2024
1Acyclovir (Aciclovir)FDA LinkGeneric
03/2024
1ORALIT (ORS)IBA
02/2024
1Messenger RNA (mRNA)IBA
12/2023
1ruxolitinibIBA
12/2023
1PotassiumIBA
12/2023
12-5A-dependent ribonuclease (RNase L)IBA
10/2023
1Type I Tumor Necrosis Factor ReceptorsIBA
01/2023
1Oxygen (Dioxygen)IBA
01/2023
1Interferon LambdaIBA
01/2023
1Interleukin-12 Subunit p40IBA
01/2023
1Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link
11/2022
1P-2 (P 2)IBA
10/2022
1mRNA VaccinesIBA
06/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Caspase 3 (Caspase-3)IBA
01/2022
1InflammasomesIBA
01/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2021
1Interleukin-5 (Interleukin 5)IBA
01/2021
1Interleukin-13IBA
01/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021
1Prednisolone (Predate)FDA LinkGeneric
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Attenuated VaccinesIBA
01/2021

Therapy/Procedure

2Critical Care (Surgical Intensive Care)
01/2022 - 11/2021
2Artificial Respiration (Mechanical Ventilation)
01/2022 - 01/2021
2Therapeutics
01/2021 - 01/2021
1Drug Therapy (Chemotherapy)
04/2024
1Plasma Exchange
01/2021